138 related articles for article (PubMed ID: 2874759)
1. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction.
Postma DS; de Vries K; Koëter GH; Sluiter HJ
Am Rev Respir Dis; 1986 Aug; 134(2):276-80. PubMed ID: 2874759
[TBL] [Abstract][Full Text] [Related]
2. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
Postma DS; Peters I; Steenhuis EJ; Sluiter HJ
Eur Respir J; 1988 Jan; 1(1):22-6. PubMed ID: 3366234
[TBL] [Abstract][Full Text] [Related]
3. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.
Stănescu D; Sanna A; Veriter C; Robert A
Chest; 1998 Aug; 114(2):416-25. PubMed ID: 9726724
[TBL] [Abstract][Full Text] [Related]
4. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility.
Postma DS; Gimeno F; van der Weele LT; Sluiter HJ
Eur J Respir Dis; 1985 Nov; 67(5):360-8. PubMed ID: 3878797
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in severe chronic obstructive pulmonary disease.
Postma DS; Burema J; Gimeno F; May JF; Smit JM; Steenhuis EJ; Weele LT; Sluiter HJ
Am Rev Respir Dis; 1979 Mar; 119(3):357-67. PubMed ID: 443616
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of chronic obstructive pulmonary disease: the Dutch experience.
Postma DS; Sluiter HJ
Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S100-5. PubMed ID: 2782755
[TBL] [Abstract][Full Text] [Related]
7. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
[TBL] [Abstract][Full Text] [Related]
8. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study.
Wise RA; Enright PL; Connett JE; Anthonisen NR; Kanner RE; Lindgren P; O'Hara P; Owens GR; Rand CS; Tashkin DP
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):866-72. PubMed ID: 9517604
[TBL] [Abstract][Full Text] [Related]
9. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.
Stănescu D; Sanna A; Veriter C; Kostianev S; Calcagni PG; Fabbri LM; Maestrelli P
Thorax; 1996 Mar; 51(3):267-71. PubMed ID: 8779129
[TBL] [Abstract][Full Text] [Related]
10. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction.
Postma DS; Renkema TE; Noordhoek JA; Faber H; Sluiter HJ; Kauffman H
Am Rev Respir Dis; 1988 Jan; 137(1):57-61. PubMed ID: 2827548
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
12. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group.
Brand PL; Kerstjens HA; Postma DS; Sterk PJ; Quanjer PH; Sluiter HJ; Dijkman JH; van Herwaarden CL; Hilvering C; Jansen HM
Eur Respir J; 1992 Jan; 5(1):21-31. PubMed ID: 1533595
[TBL] [Abstract][Full Text] [Related]
13. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
14. Rapidly decreasing forced expiratory volume in one second or vital capacity and development of chronic airflow obstruction.
Clément J; Van de Woestijne KP
Am Rev Respir Dis; 1982 May; 125(5):553-8. PubMed ID: 7081815
[TBL] [Abstract][Full Text] [Related]
15. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease.
Pope CA; Kanner RE
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1336-40. PubMed ID: 8503541
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.
Koumbourlis AC; Motoyama EK; Mutich RL; Mallory GB; Walczak SA; Fertal K
Pediatr Pulmonol; 1996 Jan; 21(1):28-34. PubMed ID: 8776263
[TBL] [Abstract][Full Text] [Related]
18. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group.
Tashkin DP; Altose MD; Bleecker ER; Connett JE; Kanner RE; Lee WW; Wise R
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):301-10. PubMed ID: 1736734
[TBL] [Abstract][Full Text] [Related]
19. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.
Rijcken B; Schouten JP; Xu X; Rosner B; Weiss ST
Am J Respir Crit Care Med; 1995 May; 151(5):1377-82. PubMed ID: 7735588
[TBL] [Abstract][Full Text] [Related]
20. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second.
Tashkin DP; Detels R; Simmons M; Liu H; Coulson AH; Sayre J; Rokaw S
Am J Respir Crit Care Med; 1994 May; 149(5):1209-17. PubMed ID: 8173761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
